Epigenetic Regulation of the Metallothionein 3 Gene in Esophageal Adenocarcinomas
Author Information
Author(s): Peng Dun, Hu Tian-Ling, Jiang Aixiang, Washington Mary Kay, Moskaluk Christopher A., Schneider-Stock Regine, El-Rifai Wael
Primary Institution: Vanderbilt University Medical Center
Hypothesis
The study investigates the epigenetic alterations and gene expression of the MT3 gene in esophageal adenocarcinomas (EACs).
Conclusion
Esophageal adenocarcinomas are characterized by frequent epigenetic silencing of the MT3 gene due to specific DNA methylation changes.
Supporting Evidence
- DNA methylation levels from specific regions of the MT3 promoter showed a strong correlation with MT3 gene expression.
- Hypermethylation of the MT3 promoter was significantly associated with advanced tumor stages and lymph node metastasis.
- Treatment with 5-Aza restored MT3 expression in silenced cancer cells.
Takeaway
The study found that a gene called MT3 is often turned off in a type of esophageal cancer because of changes in its DNA.
Methodology
The study used quantitative bisulfite pyrosequencing to analyze DNA methylation and real-time RT-PCR to assess gene expression.
Participant Demographics
The study included 78 esophageal adenocarcinoma samples, 5 Barrett's esophagus samples, 33 normal esophagus samples, and 28 normal stomach samples.
Statistical Information
P-Value
p<0.0001
Statistical Significance
FDR<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website